ABSTRACT
A total of 65 isolates of Staphylococcus aureus (25) and
Escherichia coil (30) were isolated from different clinical samples. Bioflim
formation was determined in trypticase soy broth and brain heart infusion broth
using three different methods (Tissue culture plate method, Tube method and
Congo red agar method). The result shows that biofilm production was detected
by all the methods. Positive cases were more frequently observed in tissue
culture plate method (high; 30.8%) than in tube method (high; 24.6%) and congo
red agar method (high; 15 4%). The influence of incubation temperature on
bioflim formation was investigated at 22°C, 3Ø0 C and 37°C. The mean quantities
of bioflim formed at 30°C (0.42±0.0 1) were higher than those formed at both
37°C (0.35±0.03) and 22°C (0.28±0.01). The biofilm formation was high under
aerobic conditions and low under anaerobic conditions. The amount of biofilm
formed by all the isolates decreased with decrease in pH. The amount of biofllm
produced in pH 3 (0.01±0.01) and pH 5 (0.05±0.01) were very low compared to
formation at pH 9 and 12. Biofilm formed on glass and catheter surfaces and the
amount formed was directly proportional to the duration of cultivation. The
amount increased significantly with increase in time. Supplementation of the
culture medium with sugars yielded an increase in bioflim production. All S.
aureus isolates tested were resistant to penicillin, ceftazidime, chloramphenicol,
cotrimoxazole, clinafloxacin. All S. aureus isolates were susceptible to
gentamicin ofloxacin and augmentin, while 60% were susceptible to rifampin and
ceftriaxone. All E. coil isolates were resistant to ceftriaxone,
chloramphenicol and ciprofloxacin and were susceptible to gentamicin and
nalixidic acid, while 60% were susceptible to ofloxacin and levofloxacin.
Biofilm formation is best studied with the tissue culture plate method under
aerobic conditions at 30°C or 37°C in neutral or alkaline pH. It is enhanced by
sugar supplementation. Gentamicin, augmentin and ofloxacin are effective
against S. aureus and E. coii.
NWAONU, C (2021). Detection Of Biofilm Formation Among Clinical Isolates Of Staphylococcus Aureus And Escherichia Coil. Mouau.afribary.org: Retrieved Nov 16, 2024, from https://repository.mouau.edu.ng/work/view/detection-of-biofilm-formation-among-clinical-isolates-of-staphylococcus-aureus-and-escherichia-coil-7-2
CHIDIEBERE, NWAONU. "Detection Of Biofilm Formation Among Clinical Isolates Of Staphylococcus Aureus And Escherichia Coil" Mouau.afribary.org. Mouau.afribary.org, 12 Oct. 2021, https://repository.mouau.edu.ng/work/view/detection-of-biofilm-formation-among-clinical-isolates-of-staphylococcus-aureus-and-escherichia-coil-7-2. Accessed 16 Nov. 2024.
CHIDIEBERE, NWAONU. "Detection Of Biofilm Formation Among Clinical Isolates Of Staphylococcus Aureus And Escherichia Coil". Mouau.afribary.org, Mouau.afribary.org, 12 Oct. 2021. Web. 16 Nov. 2024. < https://repository.mouau.edu.ng/work/view/detection-of-biofilm-formation-among-clinical-isolates-of-staphylococcus-aureus-and-escherichia-coil-7-2 >.
CHIDIEBERE, NWAONU. "Detection Of Biofilm Formation Among Clinical Isolates Of Staphylococcus Aureus And Escherichia Coil" Mouau.afribary.org (2021). Accessed 16 Nov. 2024. https://repository.mouau.edu.ng/work/view/detection-of-biofilm-formation-among-clinical-isolates-of-staphylococcus-aureus-and-escherichia-coil-7-2